Biden to receive vaccine
WASHINGTON ( AP) — The leader of the Trump administration's vaccination program says people who have been infected with the coronavirus — a group that includes President Donald Trump — should be vaccinated.
Moncef Slaoui, the chief adviser of Operation Warp Speed, told CNN'S "State of the Union" on Sunday that the vaccine is safe for those who have recovered and offers stronger and potentially longer protection than does the virus itself.
"We know that infection doesn't induce a very strong
immune response and it wanes over time. So I think, as a clear precaution, it is appropriate to be vaccinated because it's safe," he said. "I think people should be vaccinated, indeed."
Trump has not received the first of two vaccination shots, which began being administered last week as part of the largest vaccination campaign in the nation's history. Vice President Mike Pence, House Speaker Nancy Pelosi, D- Calif., and Senate Majority Leader Mitch Mcconnell, R- Ky., all were given doses Friday. Presidentelect Joe Biden was to receive his Monday.
All have chosen to publicize their injections as part of a campaign to convince a skeptical public that the vaccines are safe and effective, in hopes of finally putting an end to a pandemic that has killed more than 310,000 people in the United States and upended life around the globe.
Trump has spent the last week largely out of sight as he continues to stew about his election loss and floats increasingly outlandish schemes to remain in power. It's an approach that has bewildered top aides who see his silence as a missed opportunity for the president, who leaves office Jan. 20, to claim credit for helping oversee the speedy development of the vaccine and to burnish his legacy.
Trump was hospitalized with COVID- 19 in October and given an experimental monoclonal antibody treatment that he credited for his swift recovery.
The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices said the Pfizer- Biontech vaccine, which was the first to receive authorization, "is safe and likely efficacious" in people who have been infected with COVID- 19 and "should be offered regardless of history of prior symptomatic or asymptomatic SARS- COV- 2 infection."